StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.70−0.06 (-1.60%)

Close on Nov 17, 2026Market cap $464.39MP/E –Yield –

Aquestive Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Aquestive Therapeutics's EV/EBITDA was 20.2× on Jan 31, 2019.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201920.2×−1.0
2018Dec 31, 201821.1×–

More Aquestive Therapeutics figures

See a number that looks wrong?